Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Epicenter who wrote (7432)	4/17/1999 11:29:00 AM
From: BigKNY3	Read Replies (1) \| Respond to of 9523

The Big Pharma Report: 4/17/99 Have a PFun Weekend! BigKNY3 ________________________________________________________ Big Pharma Scoreboard 4/17/99 -Despite a record Dow high (10,494)and a weekly gain of 3.1%, all other markets headed down (S&P -2.2% and NASTie -4.3%). -Big Pharma took a major 8.2% hit this week and now is basically even for the year (+0.4%). - Every Big Pharma declined this week led by the #1 leader AMGN (-14.4%). -Despite meeting 1 Qt EPS Consensus, PFE declined 13.0% after reaching its all-time high on Monday (150.13). YTD PFE is up only 1.7%. -Six Big Pharmas are currently showing YTD declines; GLX (-12.6%), WLX (-10.4%), BMY (-8.3%), LLY (-7.4%), SGP (-5.0%), and SBH (-4.0%). . Price % Chg % Chg % Chg Rank . 04/16/99 Week April YTD 1999 1 Amgen 66.81 -14.4% -10.8% 27.8% 2 Amer 62.69 -8.3% -3.9% 11.2% 3 J&J 93.13 -5.0% -0.4% 11.0% 4 Merck 77.63 -6.8% -3.1% 5.3% 5 Pharma 58.81 -5.9% -5.7% 3.9% 6 Pfizer 127.06 -13.0% -8.3% 1.7% 7 Abbott 49.06 -3.7% 4.8% 0.1% 8 Smith 66.69 -4.9% -5.0% -4.0% 9 Scher 52.50 -12.2% -6.7% -5.0% 10 Lilly 82.31 -8.8% -3.2% -7.4% 11 Bristol 61.38 -5.3% -4.3% -8.3% 12 Warner 67.38 -5.4% 1.7% -10.4% 13 Glaxo 60.75 -8.0% -9.2% -12.6% Big Pharma 71.25 -8.2% 3.4% 0.4% Dow 10,494 3.1% 5.1% 14.3% S&P 500 1,319 -2.2% 3.9% 7.3% NASDAQ 2,482 -4.3% 7.6% 13.2% News/chart/quote links to Big Pharma and ED stocks: Yahoo! PFE News biz.yahoo.com Five Day Chart of PFE versus the Dow quicken.com A great PFE Stat Website dailystocks.com Labpuppy.com Drug Stock Commentary (scroll down after opening) labpuppy.com A New Investment Website Worth A Try bridge.com Big Pharma Yahoo Link quote.yahoo.com Motley Fool Link quote.fool.com ED Stocks Yahoo Link quote.yahoo.com Motley Fool Link quote.fool.com PFE Split Information -On the April 22, 1999 Annual Meeting, PFE shareholders will officially approved an increase in authorized outstanding shares that will permit a 3-1 split. -Following the Annual Meeeting, the PFE Board is scheduled to meet and announce the 3-1 split and its effective date....Expected to be following the June 30, 1999 close. The 1999 Pharma Portfolio Challenge: Motley Fool /SI Challenge Highlights -The impact of last week's decline was felt throughout the Portfolio Challenge. A total of only 58% of the portfolios are in the black as compared to 94% last week. -Ron Flanagan (+11.5% down from 26.1% last week ) remains #1 with an equal trifecta of PFE/MRK/AMGN (Portfolio: 33% PFE/MRK/AMGN, 1% Cash). -MERCKGAL (+11.1%) moved up to #2 with her play on AHP (Portfolio: AHP 99%, MRK 1%). -McMenus(+10%%) remains in the place position (Portfolio: 40% PFE, 25% AMGN/MRK, 10%:JNJ) -The five 100% PFErs (+1.7%) dropped to 25th place (Portfolio: 100% PFE) -Supporting the principles behind the Peabody Model: PEABODY PURCHASE (+3.4%) is beating the PFE DRIP (+0.9%). -An interesting portfolio this week is the PEABODY PEAK SHORT (+7.2%). This portfolio shorts PFE at confirmed Peabody Peaks (in the amount of $833 representing 1/12th of the original cah investment of $10,000). (Portfolio: 63% cash, 17.50 shares short PFE) purchased at the 3 1999 Peabody Peaks; 134.63, 144.50, and 150.13) -SHORT COX II (-3.5%) is in 60th place (Portfolio: 50% short PFE; 50% short MRK) -SHORT PFE (-1.7%) moved up to 47 th place (Portfolio: 100% short PFE) -A complete ranking of the 65 portfolios is posted on AOL's PFE BInvestment Board. For 1999, the following 8 composite portfolios have been created for comparative purposes: -BIG PHARMA- Portfolio is indexed versus the Big Pharma growth rate -CASH- Portfolio is 100% in cash with a fixed 5% annual return -PEABODY PURCHASE- Portfolio was originally 100% in cash with $833 purchases of PFE at Peabody Pending Valleys as called by Mr. P -PFE DRIP- Portfolio is 100% in cash with a $833 monthly DRIP for PFE -PFE DRIP SHORT- Portfolio is 100% in cash with a $833 monthly DRIP for shorting PFE -SHORT COX II- Portfolio is 50% short PFE and 50% short MRK -SHORT PFE- Portfolio is 100% short PFE. PEABODY PEAK SHORT**- Portfolio was originally 100% in cash with $833 short purchases of PFE at confirmed Peabody Peaks. Click here for a breakdown of the holdings of the 64 Challenge portfolios www3.techstocks.com